EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Cadmium Impairs p53 Activity in HepG2 Cells

C Urani, P Melchioretto, M Fabbri, G Bowe, E Maserati, L Gribaldo

ISRN Toxicology · 13.03.2014 · 2014 · 1-9

DOI: 10.1155/2014/976428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Toxicology, erschienen am 13.03.2014. Verfasst von C Urani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Earth and Environmental Sciences, University of Milano Bicocca, piazza della Scienza 1, 20126 Milan, Italy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: European Commission, University of Milan Bicocca, Institute for Health and Consumer Protection.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cadmium and cadmium compounds are contaminants of the environment, food, and drinking water and are important constituents of cigarette smoke. Cd exposure has also been associated with airborne particulate CdO and with Cd-containing quantum dots in medical therapy. Adverse cadmium effects reported in the literature have stimulated during recent years an ongoing discussion to better elucidate cadmium outcomes at cell and molecular level. The present work is designed to gain an insight into the mechanism of p53 impairment at gene and protein level to understand Cd-induced resistance to apoptosis. We used a hepatoma cell line (HepG2) derived from liver, known to be metal responsive. At genotoxic cadmium concentrations no cell cycle arrest was observed. The p53 at gene and protein level was not regulated. Fluorescence images showed that p53 was correctly translocated into the nucleus but that the p21 Cip1/WAF-1 , a downstream protein of p53 network involved in cell cycle regulation, was not activated at the highest cadmium concentrations used. The miRNAs analysis revealed an upregulation of mir-372, an miRNA able to affect p21 Cip1/WAF-1 expression and promote cell cycle progression and proliferation. The role of metallothioneins and possible conformational changes of p53 are discussed.

Autor:innen und Institutionen

  • Department of Earth and Environmental Sciences, University of Milano Bicocca, piazza della Scienza 1, 20126 Milan, Italy.
  • Institute for Health and Consumer Protection, Joint Research Centre, Via Enrico Fermi 2749, 21027 Ispra, Italy ; Dipartimento di Medicina Clinica e Sperimentale, Università dell'Insubria, 21100 Varese, Italy.
  • Institute for Health and Consumer Protection, Joint Research Centre, Via Enrico Fermi 2749, 21027 Ispra, Italy.
  • Dipartimento di Medicina Clinica e Sperimentale, Università dell'Insubria, 21100 Varese, Italy.

Förderung

  • European Commission
  • University of Milan Bicocca
  • Institute for Health and Consumer Protection

Zitieren

APA

Urani, C., Melchioretto, P., Fabbri, M., Bowe, G., Maserati, E., & Gribaldo, L. (2014). Cadmium Impairs p53 Activity in HepG2 Cells. ISRN Toxicology, 2014, 1-9. https://doi.org/10.1155/2014/976428

Vancouver

Urani C, Melchioretto P, Fabbri M, Bowe G, Maserati E, Gribaldo L. Cadmium Impairs p53 Activity in HepG2 Cells. ISRN Toxicology. 2014;2014:1-9. doi:10.1155/2014/976428

BibTeX
@article{Urani2014,
  author = {Urani, C and Melchioretto, P and Fabbri, M and Bowe, G and Maserati, E and Gribaldo, L},
  title = {Cadmium Impairs p53 Activity in HepG2 Cells},
  journal = {ISRN Toxicology},
  year = {2014},
  volume = {2014},
  pages = {1--9},
  doi = {10.1155/2014/976428}
}
Kostenlos starten →